Trials / Completed
CompletedNCT00403975
Study of Diquafosol Tetrasodium Ophthalmic Solution in Subjects With Dry Eye Disease
A Multi-Center, Parallel Group, Double-Masked, Randomized, Placebo-Controlled Study of Multiple Ocular Instillations of Diquafosol Tetrasodium Ophthalmic Solution, 2% in Subjects With Dry Eye Disease
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 640 (actual)
- Sponsor
- Merck Sharp & Dohme LLC · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this trial is to assess the effectiveness and safety of 2% diquafosol tetrasodium ophthalmic solution versus placebo following 6 weeks of treatment in subjects with mild to moderate dry eye disease.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | diquafosol tetrasodium ophthalmic solution, 2% |
Timeline
- Start date
- 2004-06-01
- Primary completion
- 2004-11-01
- Completion
- 2004-11-01
- First posted
- 2006-11-27
- Last updated
- 2016-02-22
Source: ClinicalTrials.gov record NCT00403975. Inclusion in this directory is not an endorsement.